Analytical Chemistry · 2022 · 24 citations · 29 references
Life SciencesBiotechnologyMolecular BiologyBiosensorsNanomaterialsVirologyDna NanotechnologyInfectious Disease Molecular TestingNanomedicineNucleic Acid BiosensorsOligonucleotide ChemistryRna-based DiagnosticsAntisense Oligonucleotide DesignAntisense RnasGold Nanoparticle BiosensorsLocalized Surface Plasmon Resonance BiosensorsNanoparticlesReal-time Polymerase Chain Reaction AssaysSurface Plasmon Resonance BiosensorsViral Genome Detection
A naked-eye (equipment-free), label-free (cost-effective), and RNA extraction-free (to speed up) method for SARS-CoV-2 (as a case study of RNA viruses) detection is developed. Here, the DNA is being used as a template for in situ formation of anisotropic gold nanoparticles (AuNPs) without any chemical modification or DNA labeling. In this study, synthesized AuNPs for the direct detection of N-gene (nucleocapsid phosphoprotein) of SARS-CoV-2 are exploited. To this aim, antisense oligonucleotides (ASOs) with an extra poly guanine tail (G12) were designed. Thus, in the presence of its viral target RNA gene and ASOs@AuNPs-RNA hybridization, there was a red shift in its localized surface plasmon resonance (LSPR), and the intensity of the LSPR peak at 690 nm of throat swab samples was compared to the threshold cycle (Ct) of a reverse-transcriptase real-time polymerase chain reaction (RT-qPCR) (as a gold standard). Results suggested that the plasmonic biosensor can detect a very low amount of SARS-CoV-2 with a detection limit close to RT-qPCR. Simplicity of the new conjugation method with hybridization and annealing without amplification and denaturation steps enabled it to perform in a microfluidic paper-based analytical device.
29
Brian Rabe, Constance L. Cepko · Proceedings of the National Academy of Sciences · 2020 · 296 citations · Full text
Veterinary Medicine, Infectious Diseases, Molecular Diagnostics +16